Nuwellis Targets Pediatric Critical Care Expansion at KidneyBee Summit
Event summary
- Nuwellis will showcase its Aquadex SmartFlow System at the KidneyBee Summit 2026, held July 14-16 in Aurora, Colorado.
- The company aims to engage with pediatric nephrology experts on fluid management for acute kidney injury and cardiorenal conditions.
- Aquadex is increasingly used in leading U.S. pediatric centers for controlled ultrafiltration therapy.
- Nuwellis continues expanding its presence in pediatric critical care as part of a broader strategy across the heart-kidney continuum.
The big picture
Nuwellis' participation in the KidneyBee Summit underscores its strategic focus on expanding into pediatric critical care, a high-growth segment within cardiorenal therapy. The company's Aquadex SmartFlow System is positioned to address unmet needs in fluid management for acute kidney injury and fluid overload, areas where precise ultrafiltration can significantly improve patient outcomes.
What we're watching
- Pediatric Market Penetration
- How Nuwellis will leverage the KidneyBee Summit to accelerate adoption of Aquadex in pediatric critical care.
- Therapeutic Expansion
- Whether Nuwellis can sustain growth across both adult and pediatric cardiorenal patient populations.
- Competitive Positioning
- The pace at which competitors develop similar ultrafiltration technologies for pediatric use.